About Me
Richard Suder, CFA, CFP®
As the founder of Auri Elan Financial Group, I am an experienced independent financial advisor and insurance agent specializing in providing comprehensive and objective investment consultation, financial and insurance planning to individual investors, companies, select group of affluent families and entrepreneurs. Please contact me for a complimentary Portfolio Review. You deserve nothing less than a CFP and a CFA Charterholder for your finance! Securities and Advisory Services offered through LPL Financial. A Registered Investment Advisor, Member FINRA/SIPC.-
Stock Quotes
INDU 0.00 N/A
NASDAQ 2778.79 -34.90
S&P 500 1295.22 -9.64
AMGN 69.15 -1.39
JNJ 63.35 -0.20
PFE 22.57 +0.01
MRK 37.821 -0.209
NVS 51.72 +0.12
GSK 44.18 -0.17
BMY 32.72 -0.03
ABT 61.57 -0.66
AZN 41.46 -0.19
LLY 40.44 -0.09
SNY 34.19 +0.02
WX 13.35 -0.20
1969-12-31 19:00 Polls
Loading ...
BIO SmartBrief- Ship with FedEx May 18, 2012BIO has teamed up with FedEx to offer member companies discounts of up to 35% off select FedEx Express, FedEx Ground and FedE -More- […]
- Okanagan seeks Canadian approval for biotech apple May 18, 2012Okanagan Specialty Fruits has filed an application with the Canadian Food Inspection Agency seeking approval for its biotech, -More- […]
- Agilent to expand life sciences business with $2.2B Dako acquisition May 18, 2012Agilent Technologies has agreed to pay $2.2 billion to acquire Dako, a maker of cancer diagnostic systems in Denmark. -More- […]
- HGS moves to block GSK's bid May 18, 2012Human Genome Sciences has approved a shareholder-rights plan, or "poison pill," to fend off GlaxoSmithKline's $2.6 billion ta -More- […]
- Canada approves Osiris stem cell drug Prochymal for acute GvHD May 18, 2012Osiris Therapeutics obtained approval from Canadian regulators to market its stem cell drug Prochymal for children with acute -More- […]
- Ship with FedEx May 18, 2012
- In the Pipeline
- The Genetic Diversity of Cancer Cells May 18, 2012For those of you interested in the recent work on the diversity of different cancer cell genotypes inside single tumors, there's a review out that covers the field well. The authors also go into some of the major unanswered questions: does having a tumor cell population with a lot of genetic diversity correlate with a poor prognosis for treatment? Can s […]
- Strangely Good Results in Diabetes and Cardiovascular Disease May 18, 2012I've read a couple of medical papers recently that show how tricky it is to draw conclusions on what patients would be best helped by a specific therapy. Many of you will have seen the paper in The Lancet on the use of statins in low-risk patients. This isn't something you'd necessarily think would do much good - it all depends on what the ben […]
- Is HDL Always "Good Cholesterol"? May 17, 2012The failure of Roche's dalcetrapib has a lot of people wondering just what's going on with HDL as a cardiovascular drug target. And this isn't the first time - there have been a number of puzzling findings in the lipoprotein field that point out to us that we don't know nearly as much about this area as we might think. Many promising ther […]
- The Breslow Chirality Paper Mess, Resolved May 17, 2012Just a note: the Breslow origins-of-chirality paper, also known more widely (thanks to some bizarre PR work at the ACS) as the "alien dinosaur" paper, has been withdrawn, and on the correct grounds. The pun in the headline is intended. […]
- A Preventative Trial for Alzheimer's: The Right Experiment May 17, 2012Alzheimer's disease is in the news, as the first major preventative drug trial gets underway. I salute the people who have made this happen, because we're bound to learn a lot from the attempt, even while I fear the chances for success are not that good. A preventative trial for Alzheimer's would, under normal circumstances, be a nightmarish u […]
- The Genetic Diversity of Cancer Cells May 18, 2012
